David Wojciechowski, D.O.
Medical Director of the Kidney Transplantation Program
Department Internal Medicine | Surgery
You have reached the Academic Profile.
For more information on the doctor and patient care, please visit the clinical profile.View Clinical Profile
David Wojciechowski, D.O., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, a member of its Division of Nephrology, and Medical Director of the Kidney Transplantation Program. He also serves as Director of the Transplant Nephrology Fellowship Program.
Originally from Reading, Pa., Dr. Wojciechowski holds a bachelor’s degree in biology magna cum laude from St. Joseph’s University in Philadelphia. He earned his medical degree at the Philadelphia College of Osteopathic Medicine. He completed a residency in internal medicine and a fellowship in nephrology at Georgetown University Hospital/Washington Hospital Center, followed by an additional fellowship in transplant nephrology at the University of California, San Francisco.
His is certified by the American Board of Internal Medicine in nephrology.
Before joining the UT Southwestern faculty in 2019, he served as director of the Inpatient Kidney Transplant Service at UC San Francisco, and Director of Transplant Nephrology Clinical Research at Massachusetts General Hospital.
Dr. Wojciechowski’s research focuses on kidney transplantation, specifically preventing and treating post-transplant viral infections, increasing access to transplantation, and evaluating immunosuppression protocols to maximize patient outcomes and minimize toxicity. He has delivered scores of regional, national, and international presentations, contributed to the third edition of Transplantation of the Liver, and published numerous academic articles.
At UT Southwestern, Dr. Wojciechowski serves as Chair of the Data Safety Monitoring Board for the Department of Surgery, and is a member of the Solid Organ Transplant Program Planning Committee and the Kidney and Liver Clinic Oversight Committee for Clements University Hospital.
Dr. Wojciechowski is Associate Editor of the nephrology section of Frontiers in Medicine, and a Fellow of the American Society of Transplantation, where he serves on its renal transplant fellowship training accreditation committee. In addition, he is a member of the American Medical Association and American Society of Nephrology.
- Medical School
- Philadelphia College of Osteopathic Medicine (2002)
- Washington Hospital Center/Georgetown University Hospital (2005), Internal Medicine
- Chief Resident
- MedStar Health/Union Memorial Hospital (2006), Internal Medicine
- MedStar Georgetown University Hospital (2008), Nephrology
- University of California at San Francisco (2009), Transplant Nephrology
- Expansion of the Deceased Donor Pool
- Novel Immunosuppression
- Post-transplant Infections
- A Prospective Multi-Center Observational Study of Cell-Mediated Immunity as a Predictor for Cytomegalovirus Infection in Kidney Transplant Recipients.
- Kumar D, Chin-Hong P, Kayler L, Wojciechowski D, Limaye AP, Gaber AO, Ball S, Mehta AK, Cooper M, Blanchard T, MacDougall J, Kotton CN Am. J. Transplant. 2019 Feb
- Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.
- Durand CM, Halpern SE, Bowring MG, Bismut GA, Kusemiju OT, Doby B, Fernandez RE, Kirby CS, Ostrander D, Stock PG, Mehta S, Turgeon NA, Wojciechowski D, Huprikar S, Florman S, Ottmann S, Desai NM, Cameron A, Massie AB, Tobian AAR, Redd AD, Segev DL, Am. J. Transplant. 2018 10 18 10 2579-2586
- Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity.
- Gupta S, Rosales I, Wojciechowski D, J Transplant 2018 2018 1968029
- Accept or Decline? An Analytics-Based Decision Tool for Kidney Offer Evaluation.
- Bertsimas D, Kung J, Trichakis N, Wojciechowski D, Vagefi PA Transplantation 2017 Dec 101 12 2898-2904
- Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients.
- Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F, Transplant. Proc. 2017 Oct 49 8 1773-1778
- Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience.
- Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F, Clin Transplant 2017 Sep 31 9
- Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
- Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, Howard A, Wojciechowski D, Transplantation 2017 06 101 6 1495-1505
- Cultural competency of a mobile, customized patient education tool for improving potential kidney transplant recipients' knowledge and decision-making.
- Axelrod DA, Kynard-Amerson CS, Wojciechowski D, Jacobs M, Lentine KL, Schnitzler M, Peipert JD, Waterman AD, Clin Transplant 2017 05 31 5
- Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients.
- Wojciechowski D, Chandran S, Vincenti F, Clin Transplant 2017 05 31 5
Clinical and Laboratory Evaluation of Renal Disease and Fluid Status. In Handbook of Nephrology and Hypertension, 6th Ed.
Wojciechowski D, Nouri P (2008). Philadelphia, Pennsylvania, Lippincott Williams and Wilkins
Immunosuppression with the Kidney as Paradigm. In A Companion to Specialist Surgical Practice: Transplantation, 5th Ed.
Wojciechowski D, Veillette G, Vincenti F (2012). Philadelphia, Pennsylvania, Elsevier
Novel Immunosuppressive Drugs. In Transplantation of the Liver, 3rd Ed.
Wojceichowski, D, Vincenti F (2012). Elsevier